London Business Angels is a private angel network connecting innovative, fast-growing small and medium-sized enterprises with business angel investors.
Portfolio
15
companies
Albert Medical Devices
Albert Medical Devices develops intelligent urology products including the melio catheter leg bag.
Astrid & Miyu
Astrid & Miyu designs and sells contemporary jewellery for the fashion conscious consumer.
Breakbad
Breakbad builds a preventive health application that offers psychological support and analytics to help users manage cravings.
Captive Media
Captive Media operates a digital outdoor advertising network focused on male washrooms.
Contego Fraud Solutions
Contego Fraud Solutions develops risk management software for due diligence and compliance analysis.
Eagle Genomics
Eagle Genomics develops bioinformatics software for pharmaceutical and life science research.
La Salle Education
La Salle Education develops digital platforms for mathematics teaching and assessment in schools.
Night Zookeeper
Night Zookeeper transforms children drawings into interactive digital games and stories.
Ownfone
Ownfone provides customisable and accessible mobile handsets for users who find standard devices difficult to operate.
Pepper
Pepper provides white-label mobile payments and digital loyalty applications for retail and hospitality brands.
Sphere Fluidics
Sphere Fluidics develops single cell analysis and characterisation systems for biopharmaceutical discovery.
StepJockey
Promoting workplace physical activity through smart staircase labeling and gamification platforms.
Travel AI
Travel AI develops transportation software for travel personalisation and context awareness.
Vallie
Vallie provides an on demand valet parking service for drivers in London.
Videregen
Videregen develops biological scaffolds for organ replacement and regenerative medicine.
Anthony Clarke
CEO
Kayar Raghavan
Lead Angel
The Cambridge-based bioinformatics specialist has closed a £1m investment round backed by London Business Angels.
"Eagle Genomics which is now at scale up stage is commercialising an effective bioinformatics software solution that has the potential to improve the way in which new medicines and therapies are developed. This round of growth capital funding from existing and new angel investors leaves the company well positioned to accelerate its growth in this fast growing market."
London Business Angels and London Co-Investment Fund back on demand parking service Vallie.
"London is one of the most difficult and expensive places to park in the world. Our customers love Vallie and the services we provide. It’s not just parking, it’s about improving the entire car owner experience and make driving into London work for both the driver and the city. Vallie’s model can work well in almost any city across the world. This round allows Vallie to deliver on that potential immediately"
The investment round was led by an Asian corporate investor alongside existing backers to fund the commercial launch of Cyto-Mine.
"Sphere Fluidics Limited has recently successfully developed an alpha-version of its single cell analysis and characterization system (Cyto-Mine® for the biopharmaceutical discovery and development market. We have also convinced several leading biopharmaceutical companies to fund development of this system – indicating the global potential of the product. This new funding will used to develop the manufactured version of Cyto-Mine® (see image below) and enable its commercial launch later this year. This system is transformational for the Biopharmaceutical market."
London Business Angels and the London Co-Investment Fund backed the mobile payments platform to support sales and technical growth.
"Working with LBA and LCIF has provided us with the investment we need for growth and brings with it well connected investors with a strategic interest. We have already seen the power of our current momentum, signing up four new customers in the UK and US."
The investment round was led by London Business Angels to support international growth and product development.
"We are delighted that such an experienced group of investors have backed StepJockey’s expansion. The new capital will allow us to bring our evidence-based and uniquely inclusive wellness intervention to many thousands of desk-bound office workers in the UK and around the world"
